Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.93
(-0.5%)
CNY 13.93
(-0.5%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 17.3 Billion CNY | -0.75% |
| 2022 | 17.43 Billion CNY | 19.5% |
| 2021 | 14.58 Billion CNY | 15.26% |
| 2020 | 12.65 Billion CNY | 20.78% |
| 2019 | 10.47 Billion CNY | 14.2% |
| 2018 | 9.17 Billion CNY | 18.39% |
| 2017 | 7.75 Billion CNY | 24.03% |
| 2016 | 6.24 Billion CNY | 17.44% |
| 2015 | 5.32 Billion CNY | 20.16% |
| 2014 | 4.42 Billion CNY | 24.86% |
| 2013 | 3.54 Billion CNY | 24.79% |
| 2012 | 2.84 Billion CNY | 28.11% |
| 2011 | 2.21 Billion CNY | 19.91% |
| 2010 | 1.85 Billion CNY | 27.07% |
| 2009 | 1.45 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 4.26 Billion CNY | 2.14% |
| 2024 Q1 | 5.08 Billion CNY | 12.56% |
| 2024 Q2 | 4.19 Billion CNY | -17.58% |
| 2023 Q4 | 4.52 Billion CNY | 9.29% |
| 2023 Q1 | 4.43 Billion CNY | -17.95% |
| 2023 Q2 | 4.23 Billion CNY | -4.42% |
| 2023 FY | 17.3 Billion CNY | -0.75% |
| 2023 Q3 | 4.13 Billion CNY | -2.42% |
| 2022 Q1 | 3.99 Billion CNY | -2.29% |
| 2022 FY | 17.43 Billion CNY | 19.5% |
| 2022 Q4 | 5.4 Billion CNY | 33.14% |
| 2022 Q3 | 4.06 Billion CNY | 2.29% |
| 2022 Q2 | 3.96 Billion CNY | -0.65% |
| 2021 FY | 14.58 Billion CNY | 15.26% |
| 2021 Q4 | 4.08 Billion CNY | 7.7% |
| 2021 Q3 | 3.79 Billion CNY | 16.0% |
| 2021 Q2 | 3.27 Billion CNY | -4.54% |
| 2021 Q1 | 3.42 Billion CNY | 0.32% |
| 2020 Q3 | 3.2 Billion CNY | 9.1% |
| 2020 FY | 12.65 Billion CNY | 20.78% |
| 2020 Q1 | 3.08 Billion CNY | 9.55% |
| 2020 Q2 | 2.94 Billion CNY | -4.69% |
| 2020 Q4 | 3.41 Billion CNY | 6.47% |
| 2019 Q4 | 2.81 Billion CNY | 8.32% |
| 2019 FY | 10.47 Billion CNY | 14.2% |
| 2019 Q3 | 2.6 Billion CNY | 5.21% |
| 2019 Q2 | 2.47 Billion CNY | -4.45% |
| 2019 Q1 | 2.58 Billion CNY | 1.19% |
| 2018 Q2 | 2.11 Billion CNY | -3.01% |
| 2018 Q1 | 2.17 Billion CNY | 1.39% |
| 2018 FY | 9.17 Billion CNY | 18.39% |
| 2018 Q4 | 2.55 Billion CNY | 9.87% |
| 2018 Q3 | 2.32 Billion CNY | 10.14% |
| 2017 Q2 | 1.83 Billion CNY | 1.33% |
| 2017 Q1 | 1.81 Billion CNY | 5.82% |
| 2017 FY | 7.75 Billion CNY | 24.03% |
| 2017 Q4 | 2.14 Billion CNY | 10.14% |
| 2017 Q3 | 1.95 Billion CNY | 6.16% |
| 2016 Q1 | 1.47 Billion CNY | 3.02% |
| 2016 Q2 | 1.47 Billion CNY | -0.37% |
| 2016 FY | 6.24 Billion CNY | 17.44% |
| 2016 Q3 | 1.58 Billion CNY | 7.5% |
| 2016 Q4 | 1.71 Billion CNY | 8.23% |
| 2015 Q4 | 1.43 Billion CNY | 3.48% |
| 2015 FY | 5.32 Billion CNY | 20.16% |
| 2015 Q2 | 1.29 Billion CNY | 8.29% |
| 2015 Q1 | 1.19 Billion CNY | 0.44% |
| 2015 Q3 | 1.38 Billion CNY | 6.74% |
| 2014 Q2 | 1.03 Billion CNY | -0.38% |
| 2014 FY | 4.42 Billion CNY | 24.86% |
| 2014 Q4 | 1.19 Billion CNY | 2.97% |
| 2014 Q3 | 1.16 Billion CNY | 12.09% |
| 2014 Q1 | 1.03 Billion CNY | 3.69% |
| 2013 Q4 | 1 Billion CNY | 8.96% |
| 2013 FY | 3.54 Billion CNY | 24.79% |
| 2013 Q2 | 831.41 Million CNY | 4.74% |
| 2013 Q3 | 919.52 Million CNY | 10.6% |
| 2013 Q1 | 793.8 Million CNY | 0.0% |
| 2012 FY | 2.84 Billion CNY | 28.11% |
| 2011 FY | 2.21 Billion CNY | 19.91% |
| 2010 FY | 1.85 Billion CNY | 27.07% |
| 2009 FY | 1.45 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 29.99 Billion CNY | 42.322% |
| ZJAMP Group Co., Ltd. | 40.94 Billion CNY | 57.741% |
| Luyan Pharma Co.,Ltd. | 19.84 Billion CNY | 12.82% |
| Ji Yao Holding Group Co., Ltd. | 346.1 Million CNY | -4898.859% |